Product Images Repaglinide

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 3 images provide visual information about the product associated with Repaglinide NDC 63629-4866 by Bryant Ranch Prepack, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Label - lbl636294866

Label - lbl636294866

The text provides information about a tablet containing Repaglinide USP 0.5 mg with NDC code 63629-4866-1. The usual dosage details are missing but direct to scan the package insert QR code for full prescribing information. Storage guidelines advise keeping the tablets at a temperature range of 20°C to 25°C (68°F to 77°F) and protecting from moisture by ensuring bottles are tightly closed. It is emphasized to keep the tablets out of reach of children. The package contains 30 tablets and should be dispensed in a tight container with child-resistant closure. The tablets are manufactured by Aurobindo Pharma Limited and repackaged by Bryant Ranch Prepack, Inc.*

Figure 1: Repaglinide in Combination with Pioglitazone: HbA1c Values - repaglinide fig1

Figure 1: Repaglinide in Combination with Pioglitazone: HbA1c Values - repaglinide fig1

This text seems to be a table showing the change in HbA1c (%) over time for different treatment options, including Repaglinide + Pioglitazone, Repaglinide, and Pioglitazone. The x-axis represents treatment weeks, while the y-axis represents the change in HbA1c (%). The data shows how the HbA1c values change over time for each treatment group.*

Chemical Structure - repaglinide str

Chemical Structure - repaglinide str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.